Martina M McGrath, M.B.,B.Ch.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Graft Rejection | 8 | 2019 | 4426 | 0.700 |
Why?
|
Transplantation Tolerance | 2 | 2018 | 605 | 0.550 |
Why?
|
Heart Transplantation | 9 | 2020 | 3220 | 0.420 |
Why?
|
Heart Failure | 11 | 2024 | 11594 | 0.410 |
Why?
|
Levamisole | 1 | 2011 | 35 | 0.390 |
Why?
|
Immunity, Cellular | 1 | 2018 | 1557 | 0.390 |
Why?
|
T-Lymphocytes, Regulatory | 4 | 2018 | 3071 | 0.380 |
Why?
|
Dendritic Cells | 5 | 2018 | 2723 | 0.380 |
Why?
|
Drug Contamination | 1 | 2011 | 152 | 0.350 |
Why?
|
Autoimmunity | 1 | 2018 | 1358 | 0.340 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2011 | 288 | 0.330 |
Why?
|
Biphenyl Compounds | 4 | 2023 | 988 | 0.330 |
Why?
|
Cocaine-Related Disorders | 1 | 2011 | 461 | 0.300 |
Why?
|
Lymph Nodes | 4 | 2020 | 3485 | 0.280 |
Why?
|
Adjuvants, Immunologic | 1 | 2011 | 1038 | 0.260 |
Why?
|
Graft Survival | 6 | 2018 | 3794 | 0.250 |
Why?
|
Glucosides | 3 | 2024 | 498 | 0.240 |
Why?
|
Benzhydryl Compounds | 4 | 2024 | 900 | 0.240 |
Why?
|
Membrane Proteins | 3 | 2018 | 7843 | 0.230 |
Why?
|
T-Lymphocytes | 4 | 2018 | 10171 | 0.220 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2018 | 693 | 0.210 |
Why?
|
Autoimmune Diseases | 2 | 2013 | 2244 | 0.210 |
Why?
|
Cryptococcus gattii | 1 | 2021 | 2 | 0.200 |
Why?
|
Drug Delivery Systems | 3 | 2019 | 2211 | 0.200 |
Why?
|
Hyperkalemia | 1 | 2023 | 231 | 0.190 |
Why?
|
Arteriovenous Shunt, Surgical | 3 | 2008 | 292 | 0.190 |
Why?
|
Stroke Volume | 7 | 2024 | 5460 | 0.190 |
Why?
|
Reperfusion Injury | 2 | 2018 | 1022 | 0.180 |
Why?
|
Kidney Failure, Chronic | 3 | 2023 | 2457 | 0.180 |
Why?
|
Cryptococcosis | 1 | 2021 | 104 | 0.180 |
Why?
|
Skin Transplantation | 2 | 2017 | 1083 | 0.180 |
Why?
|
Kidney Transplantation | 3 | 2023 | 4217 | 0.160 |
Why?
|
Nanoparticles | 3 | 2019 | 1940 | 0.150 |
Why?
|
Kidney | 4 | 2023 | 7016 | 0.150 |
Why?
|
Hypotension | 1 | 2023 | 879 | 0.150 |
Why?
|
Tacrolimus | 2 | 2018 | 733 | 0.150 |
Why?
|
Class Ib Phosphatidylinositol 3-Kinase | 1 | 2017 | 43 | 0.140 |
Why?
|
Interleukin-6 | 2 | 2018 | 3208 | 0.140 |
Why?
|
Transplants | 1 | 2019 | 206 | 0.140 |
Why?
|
Nanomedicine | 1 | 2019 | 288 | 0.140 |
Why?
|
Hemodiafiltration | 1 | 2016 | 18 | 0.140 |
Why?
|
Granzymes | 1 | 2017 | 276 | 0.130 |
Why?
|
HMGB1 Protein | 1 | 2016 | 137 | 0.120 |
Why?
|
Fibrosis | 2 | 2020 | 2038 | 0.120 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2018 | 478 | 0.120 |
Why?
|
Uric Acid | 1 | 2020 | 803 | 0.120 |
Why?
|
Drug Carriers | 1 | 2018 | 705 | 0.110 |
Why?
|
Renal Replacement Therapy | 1 | 2016 | 281 | 0.110 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2024 | 2115 | 0.110 |
Why?
|
Ventricular Function, Left | 2 | 2022 | 3858 | 0.100 |
Why?
|
Myocardial Infarction | 2 | 2023 | 11424 | 0.100 |
Why?
|
Drug Combinations | 3 | 2023 | 2020 | 0.100 |
Why?
|
Angiotensin Receptor Antagonists | 3 | 2023 | 1016 | 0.100 |
Why?
|
Myeloblastin | 1 | 2011 | 101 | 0.100 |
Why?
|
Organ Transplantation | 1 | 2021 | 1150 | 0.090 |
Why?
|
Lymphocyte Activation | 3 | 2017 | 5490 | 0.090 |
Why?
|
Stroke | 2 | 2023 | 9696 | 0.090 |
Why?
|
Th1 Cells | 2 | 2013 | 1031 | 0.090 |
Why?
|
Renal Dialysis | 3 | 2008 | 1786 | 0.090 |
Why?
|
Angiotensins | 2 | 2022 | 143 | 0.090 |
Why?
|
Cardiomyopathies | 1 | 2022 | 1944 | 0.090 |
Why?
|
Mice, Inbred BALB C | 5 | 2018 | 6209 | 0.090 |
Why?
|
Immunosuppressive Agents | 4 | 2018 | 4158 | 0.090 |
Why?
|
Fibroblasts | 1 | 2020 | 4087 | 0.090 |
Why?
|
Transplantation | 1 | 2011 | 218 | 0.090 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2024 | 12076 | 0.080 |
Why?
|
Mice | 12 | 2020 | 81107 | 0.080 |
Why?
|
Vasculitis | 1 | 2013 | 522 | 0.080 |
Why?
|
Peroxidase | 1 | 2011 | 605 | 0.080 |
Why?
|
Neprilysin | 2 | 2022 | 471 | 0.080 |
Why?
|
Transplantation, Homologous | 2 | 2018 | 4809 | 0.080 |
Why?
|
Mice, Knockout | 6 | 2020 | 14354 | 0.080 |
Why?
|
Mucins | 1 | 2011 | 568 | 0.080 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2017 | 2858 | 0.080 |
Why?
|
Signal Transduction | 5 | 2018 | 23341 | 0.070 |
Why?
|
Tetrazoles | 2 | 2023 | 899 | 0.070 |
Why?
|
Immunologic Factors | 1 | 2016 | 1585 | 0.070 |
Why?
|
Mice, Inbred C57BL | 7 | 2019 | 22006 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2239 | 0.070 |
Why?
|
Acute Kidney Injury | 1 | 2018 | 1926 | 0.060 |
Why?
|
Creatinine | 1 | 2011 | 1892 | 0.060 |
Why?
|
Animals | 14 | 2020 | 167777 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2018 | 4353 | 0.060 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2022 | 1503 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2018 | 4549 | 0.060 |
Why?
|
Humans | 23 | 2024 | 758381 | 0.060 |
Why?
|
Glomerular Filtration Rate | 2 | 2024 | 2154 | 0.060 |
Why?
|
Blood Vessel Prosthesis | 1 | 2008 | 953 | 0.060 |
Why?
|
Ramipril | 1 | 2023 | 96 | 0.050 |
Why?
|
Heart | 1 | 2016 | 4382 | 0.050 |
Why?
|
Vascular Surgical Procedures | 2 | 2008 | 1470 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 2017 | 9160 | 0.050 |
Why?
|
Pregnancy Outcome | 1 | 2013 | 2907 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2016 | 3526 | 0.050 |
Why?
|
Sepsis | 1 | 2016 | 2587 | 0.050 |
Why?
|
Southeastern United States | 1 | 2021 | 92 | 0.050 |
Why?
|
Death, Sudden | 1 | 2022 | 302 | 0.050 |
Why?
|
Enalapril | 1 | 2022 | 311 | 0.040 |
Why?
|
Lymphotoxin beta Receptor | 1 | 2018 | 24 | 0.040 |
Why?
|
Enoxaparin | 1 | 2000 | 392 | 0.040 |
Why?
|
Male | 11 | 2024 | 358742 | 0.040 |
Why?
|
Transplantation, Heterotopic | 1 | 2018 | 174 | 0.040 |
Why?
|
Fracture Healing | 1 | 2000 | 437 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2023 | 15396 | 0.040 |
Why?
|
Th2 Cells | 2 | 2013 | 1047 | 0.040 |
Why?
|
Mycophenolic Acid | 1 | 2019 | 343 | 0.040 |
Why?
|
Sodium | 1 | 2022 | 1588 | 0.040 |
Why?
|
Interferon-gamma | 2 | 2018 | 3156 | 0.030 |
Why?
|
Homeodomain Proteins | 2 | 2018 | 2413 | 0.030 |
Why?
|
Serpins | 1 | 2017 | 247 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2008 | 3586 | 0.030 |
Why?
|
Caspase 3 | 1 | 2017 | 728 | 0.030 |
Why?
|
Cell Movement | 2 | 2018 | 5201 | 0.030 |
Why?
|
Immunoglobulins | 1 | 2018 | 859 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2022 | 10146 | 0.030 |
Why?
|
Polyesters | 1 | 2016 | 371 | 0.030 |
Why?
|
STAT6 Transcription Factor | 1 | 2013 | 193 | 0.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2017 | 895 | 0.030 |
Why?
|
Female | 8 | 2023 | 390316 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2017 | 1610 | 0.030 |
Why?
|
Microspheres | 1 | 2016 | 787 | 0.030 |
Why?
|
GATA3 Transcription Factor | 1 | 2013 | 152 | 0.030 |
Why?
|
Motion | 1 | 2016 | 779 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2017 | 1871 | 0.030 |
Why?
|
Aged | 5 | 2024 | 168217 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 2013 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2022 | 2621 | 0.030 |
Why?
|
Hospitalization | 2 | 2022 | 10653 | 0.020 |
Why?
|
Cause of Death | 1 | 2022 | 3674 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2022 | 58681 | 0.020 |
Why?
|
Tissue Donors | 1 | 2021 | 2311 | 0.020 |
Why?
|
Antigens, Surface | 1 | 2016 | 1607 | 0.020 |
Why?
|
Microscopy | 1 | 2016 | 884 | 0.020 |
Why?
|
Video Recording | 1 | 2016 | 954 | 0.020 |
Why?
|
Maternal-Fetal Exchange | 1 | 2013 | 463 | 0.020 |
Why?
|
Models, Animal | 1 | 2017 | 2112 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2013 | 819 | 0.020 |
Why?
|
Middle Aged | 4 | 2023 | 219560 | 0.020 |
Why?
|
Glucose | 1 | 2022 | 4336 | 0.020 |
Why?
|
Preoperative Care | 1 | 2019 | 2249 | 0.020 |
Why?
|
Transplantation Immunology | 1 | 2012 | 532 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2018 | 18125 | 0.020 |
Why?
|
Interleukin-4 | 1 | 2013 | 1130 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2017 | 18942 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2017 | 1807 | 0.020 |
Why?
|
Inflammation | 2 | 2019 | 10719 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2018 | 1931 | 0.020 |
Why?
|
Antibodies | 1 | 2016 | 2420 | 0.020 |
Why?
|
Artifacts | 1 | 2016 | 1897 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 54136 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2021 | 5273 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2016 | 2297 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2020 | 12262 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9518 | 0.020 |
Why?
|
Anticoagulants | 1 | 2000 | 4778 | 0.020 |
Why?
|
Immunoconjugates | 1 | 2012 | 949 | 0.020 |
Why?
|
Kinetics | 1 | 2012 | 6371 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2008 | 2114 | 0.010 |
Why?
|
Postoperative Complications | 2 | 2008 | 15638 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2012 | 2532 | 0.010 |
Why?
|
Apoptosis | 1 | 2017 | 9468 | 0.010 |
Why?
|
Cytokines | 1 | 2016 | 7338 | 0.010 |
Why?
|
Bony Callus | 1 | 2000 | 36 | 0.010 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2013 | 2496 | 0.010 |
Why?
|
Adult | 2 | 2013 | 219916 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10417 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 11894 | 0.010 |
Why?
|
Rib Fractures | 1 | 2000 | 128 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2021 | 80170 | 0.010 |
Why?
|
Risk Factors | 1 | 2023 | 73806 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2013 | 11471 | 0.010 |
Why?
|
Rabbits | 1 | 2000 | 4771 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 64379 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2013 | 26182 | 0.010 |
Why?
|
Mutation | 1 | 2017 | 29915 | 0.010 |
Why?
|
Pregnancy | 1 | 2013 | 29742 | 0.010 |
Why?
|
Incidence | 1 | 2008 | 21273 | 0.010 |
Why?
|
Bone and Bones | 1 | 2000 | 2560 | 0.010 |
Why?
|
Time Factors | 1 | 2008 | 39873 | 0.000 |
Why?
|
Thrombosis | 1 | 2000 | 2929 | 0.000 |
Why?
|
Young Adult | 1 | 2013 | 58808 | 0.000 |
Why?
|
Adolescent | 1 | 2013 | 87888 | 0.000 |
Why?
|